Emma Hoo

Emma focuses on care redesign, measurement, and payment reform initiatives, including assessment of Accountable Care Organizations, adoption of common ACO quality and efficiency measures. Current activities to expand use of patient-reported outcomes measures (PROMs) include several community-wide pilots in oncology care (health-related quality of life, pain management and fatigue), depression, and other mental health conditions. PBGH was awarded a CMS MACRA Cooperative Agreement to develop PROMs for curative care in breast, lung, and colon cancer in collaboration with the Michigan Oncology Quality Consortium and Alliance of Dedicated Cancer Centers. Emma has also managed joint purchasing and performance measurement initiatives for health plan, pharmacy benefit, and disease management services on behalf of PBGH members. She has also evaluated and implemented data analytic solutions on behalf of large purchasers. Other initiatives include implementation and evaluation of an Intensive Outpatient Care Program for high-risk people. Emma currently participates in the Business Action Collaborative of the IOM Roundtable on Population Health Improvement and on the Implementing Value Models and Advanced Payer/Provider Workgroups of the Health Care Transformation Task Force.

Emma has served on the NCQA Disease Management Measurement Advisory Panel and National Quality Forum Behavioral Health Measures Committee. She has authored papers on ACOs, provider network management and design, consumer-directed health plans, private exchanges, and quality reporting requirements for health insurance exchanges. Previously, Emma was director of operations for a Northern California medical group, with responsibility for contracting, data analysis, and information systems. She received her bachelor of arts in social studies from Harvard University.